For 25 years, scientists have studied “SuperAgers”—people aged 80 and above whose memory rivals those decades younger.

Introduction Visual perception is a fundamental skill that plays a central role in sensing the external environment. Deficits can lead to impairments in everyday activities. Visual perception is known ...

“We are pleased to welcome Nilay Patel to Cingulate at such a pivotal time in our company’s progression,” said Shane J. Schaffer, Chairman and CEO of Cingulate. “As we file to seek ...

Zhang et al. observed that the strength of SC-FC coupling in motor- and cognition-related regions, such as the SMA and the posterior cingulate gyrus, was significantly decreased in non-acute ...

Cingulate Inc. completes FDA Pre-NDA meeting for ADHD drug CTx-1301 and secures $3 million grant for anxiety treatment CTx-2103.

NDA Submission On-Target for Mid-2025 KANSAS CITY, Kan., April 03, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed ...

Cingulate Inc. submitted CTx-1301 Phase 3 safety data to the FDA, preparing for a Pre-NDA meeting on April 2, 2025.

After a Tuesday hearing, the CEO and chairman of a Kansas City, Kansas, public company concludes a case stemming from an aggravated domestic battery charge.

Cingulate Inc. (NASDAQ:CING), a micro-cap pharmaceutical company with a market value of $16.4 million specializing in the development of central nervous system (CNS) therapeutics, has announced ...